Crossmark

Human-in-the-loop artificial intelligence for drug-shortage recurrence-risk ranking and synthetic inventory-policy simulation using U.S. Food and Drug Administration Data

Crossref DOI link: https://doi.org/10.1007/s44163-026-02144-9

Published Online: 2026-09-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Md Raisul Islam

Al Mamun, Abdullah

Tahsin, Muhtasib Sarker
License Information

Text and Data Mining valid from 2026-09-07

Version of Record valid from 2026-09-07
More Information

Article History

Received: 18 May 2026

Accepted: 26 August 2026

First Online: 7 September 2026

Declarations

Ethical approval and consent to participate: Not applicable. The study used publicly available, non-identifiable secondary data and simulated operational variables. It did not involve human participants, animals, patient-level data, clinical intervention, or human-subject experimentation. Not applicable.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below